Credit Suisse’s Aclaris Therapeutics ACRS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q1 | – | Sell |
|
|||||
|
2023
Q4 | $142K | Buy |
|
|||||
|
2023
Q3 | $679K | Buy |
|
|||||
|
2023
Q2 | $981K | Buy |
|
|||||
|
2023
Q1 | $536K | Buy |
|
|||||
|
2022
Q4 | $1.02M | Buy |
|
|||||
|
2022
Q3 | $652K | Buy |
|
|||||
|
2022
Q2 | $515K | Buy |
|
|||||
|
2022
Q1 | $550K | Buy |
|
|||||
|
2021
Q4 | $418K | Buy |
|
|||||
|
2021
Q3 | $499K | Buy |
|
|||||
|
2021
Q2 | $456K | Buy |
|
|||||
|
2019
Q3 | – | Sell |
|
|||||
|
2019
Q2 | $113K | Buy |
|
|||||
|
2019
Q1 | $200K | Buy |
|
|||||
|
2018
Q4 | $245K | Buy |
|
|||||
|
2018
Q3 | $340K | Sell |
|
|||||
|
2018
Q2 | $802K | Buy |
|
|||||
|
2018
Q1 | $571K | Buy |
|
|||||
|
2017
Q4 | $759K | Buy |
|
|||||
|
2017
Q3 | $637K | Buy |
|
|||||
|
2017
Q2 | $276K | Buy |
|
|||||
|
2017
Q1 | $286K | Sell |
|
|||||
|
2016
Q4 | $524K | Buy |
|